Biotech billionaire backs a food allergy/nutrition startup; Editas recruits a CMO

Swiss biotech billionaire Ernesto Bertarelli is putting some of his cash into a new Silicon Valley startup that will look to help prevent food allergies before they can take hold. His Gurnet Point Capital is taking the lead on a $13 million Series A for Before Brands.

Cambridge, MA-based Editas has recruited Gerald Cox as its new CMO. He was most recently VP of Rare Disease Clinical Development at Sanofi Genzyme and has spent more than 20 years as a practicing clinical geneticist at Boston Children’s Hospital.

Lilly has agreed to buy out Boehringer Ingelheim’s portfolio of animal vaccines, paying $885 million for the package deal as it beefs up its work in animal-related products.

Get Endpoints News in your inbox

News reports for those who discover, develop, and market drugs. Join 13,500+ biopharma pros who read Endpoints News articles by email every day. Free subscription.

Quick Subscribe

You're subscribing to Endpoints News

John Carroll, Editor and Co-Founder

We produce two daily newsletters designed to give you a complete picture of what's important in biopharma.

Early Edition is a skimmable digest of original sources you need to see by ~7:15a ET, and our Main Edition is the daily chronicle of biotech, with every story inside the email ~11:55a ET.
2x/weekdays. Privacy policy